ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 261726 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 261726; 2) Community: the network communities that were significantly associated with the response to NSC 261726; 3) Molecule: the relationships between components within communities and NSC 261726; 4) MDR: the compounds that were significantly associated with the NSC 261726.

NSC Compound Enrichment Correlation
NSC 716223 Null 0.024797903481211 0.24205472
NSC 236657 Cyclopent[v][1,12]oxaazacyclotetracosine-1,14(11H,22aH) -dione, 12,13,23,24-tetrahydro-23,25-dihydroxy- 24-methoxy-3,22a-dimethyl-12-phenyl- (9CI) 0.0267520285931239 0.15087222
NSC 364830 Camptothecin Derivative 0.0267520285931239 0.17010341
NSC 607088 Null 0.0267520285931239 0.22434272
NSC 628560 Null 0.0267520285931239 0.15425294
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0267520285931239 0.26940162
NSC 634761 Cis-dibromocarbonylacetonitrile-bis-(triphenylphosphine) osmium(II) 0.0267520285931239 0.24496048
NSC 634766 Null 0.0267520285931239 0.25953489
NSC 648365 Insulin-Methotrexate conjugate 0.0267520285931239 0.095978296
NSC 650012 Null 0.0267520285931239 0.4353293
Total:73  Current:39    [First] [Prev] [Next] [Last]